Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024
Offer reference number: CM/PHR/22/5689
CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South of England Tranche A. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South of England Tranche B. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/PHR/22/5689/03 - NHS Framework for the supply of Omalizumab and Diroximel Fumarate for the Midlands & East and North of England. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Accord-UK Ltd | 00079585 | ~£380,950,720 estimated from lot values | - |
| AstraZeneca | 03674842 | ~£380,950,720 estimated from lot values | LOBBYIST Incisive Health Ltd (6 quarters) FTI Consulting LLP (6 quarters) Teneo Strategy Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| Aventis Pharma ltd t/a Sanofi | 01535640 | ~£380,950,720 estimated from lot values | DONOR£101K across 3 donations To: Pauline Latham MP, Derek Thomas, Labour Party |
| Biogen | 06151086 | ~£380,950,720 estimated from lot values | - |
| BIOSIMILAR COLLABORATIONS IRELAND LIMITED | - | ~£380,950,720 estimated from lot values | - |
| Celltrion Healthcare United Kingdom Limited | 11685363 | ~£380,950,720 estimated from lot values | - |
| Chugai Pharma UK Ltd | 02814621 | ~£380,950,720 estimated from lot values | - |
| Dr.Reddy's Laboratories (UK) Limited | 01729064 | ~£380,950,720 estimated from lot values | - |
| Eli Lilly & Company Ltd | 00284385 | ~£380,950,720 estimated from lot values | DONOR£9K across 1 donation To: Conservative and Unionist Party |
| Galapagos Biotech Ltd | 03400161 | ~£380,950,720 estimated from lot values | - |
| Gedeon Richter UK Ltd | 04325685 | ~£380,950,720 estimated from lot values | - |
| GlaxoSmithKline UK Limited | 04310159 | ~£380,950,720 estimated from lot values | LOBBYIST Hill & Knowlton Limited (4 quarters) Global Counsel Ltd (1 quarter) |
| Janssen-Cilag Ltd | 01027904 | ~£380,950,720 estimated from lot values | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| LEO Pharma | - | ~£380,950,720 estimated from lot values | - |
| Manx Healthcare Ltd | 02904497 | ~£380,950,720 estimated from lot values | - |
| Merck Sharpe & Dohme (UK) Limited | - | ~£380,950,720 estimated from lot values | - |
| Napp Pharmaceuticals Ltd | 03690299 | ~£380,950,720 estimated from lot values | - |
| Novartis Pharmaceuticals UK Ltd | 00119006 | ~£380,950,720 estimated from lot values | DONOR£3K across 2 donations To: Mr Nicholas Palmer LOBBYIST M&F Health (7 quarters) Sovereign Strategy Limited (1 quarter) MP LINK Mr David Lammy— Employment and earnings |
| Organon Pharmaceuticals UK Ltd | - | ~£380,950,720 estimated from lot values | - |
| Orifarm UK | 10015046 | ~£380,950,720 estimated from lot values | - |
| Pfizer Ltd | 00526209 | ~£380,950,720 estimated from lot values | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Hanover Communications International Limited (3 quarters) Ovid Consulting Ltd (3 quarters) Incisive Health Ltd (1 quarter) MHP Communications (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Roche Products Ltd | 00100674 | ~£380,950,720 estimated from lot values | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Sobi (Swedish Orphan Biovitrum Ltd) | - | ~£380,950,720 estimated from lot values | - |
| Sun Pharma UK Ltd | 02992795 | ~£380,950,720 estimated from lot values | - |
| Takeda UK Ltd | 03362860 | ~£380,950,720 estimated from lot values | LOBBYIST Hill & Knowlton Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (2 quarters) Incisive Health Ltd (1 quarter) Burkitt Communications Ltd (1 quarter) FORMER MP Sir Kevin Barron— Employment and earnings (former) |
| Teva UK Limited | 00302461 | ~£380,950,720 estimated from lot values | - |
| Thornton and Ross Ltd | 00185947 | ~£380,950,720 estimated from lot values | - |
| UCB Pharma Ltd (primary) | - | ~£380,950,720 estimated from lot values | - |
| Zentiva Pharma UK Ltd | 02158996 | ~£380,950,720 estimated from lot values | - |
Government spending data: These suppliers have received £1,162,135,411 in 5,325 payments (over £25k) from UK Health Security Agency, Manchester University NHS Foundation Trust, Department of Health and Social Care, NHS England, Guy's and St Thomas' NHS FT and 21 more public bodies (2010-04-28 to 2026-03-31).